Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.6.0.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2016
Jun. 30, 2016
Current assets:    
Cash $ 16,329 $ 23,014
Accounts receivable - trade 25 484
Accounts receivable - unbilled 75 122
Work in process 27 22
Prepaid expenses and other current assets 292 264
Total Current Assets 16,748 23,906
Fixed assets, net of accumulated depreciation 25,453 25,574
Intangible assets, net of accumulated amortization 1,960 2,092
Security deposit 27 28
Total Assets 44,188 51,600
Current liabilities:    
Accounts payable (related party of $158 and $200 as of December 31, 2016 and June 30, 2016, respectively) 731 1,177
Accrued expenses (related party of $635 and $623 as of December 31, 2016 and June 30, 2016, respectively) 905 920
Capital lease obligation - current portion 176 170
Deferred revenue 55 24
Total Current Liabilities 1,867 2,291
Capital lease obligation - net of current portion 25,175 25,265
Total Liabilities 27,042 27,556
Commitments and Contingencies
iBio, Inc. Stockholders’ Equity:    
Preferred stock - no par value; 1,000,000 shares authorized; no shares issued and outstanding 0 0
Common stock - $0.001 par value; 175,000,000 shares authorized; 89,109,410 shares issued and outstanding as of December 31, 2016 and June 30, 2016 89 89
Additional paid-in capital 67,974 67,468
Accumulated other comprehensive loss (29) (29)
Accumulated deficit (63,881) (57,591)
Total iBio, Inc. Stockholders' Equity 4,153 9,937
Noncontrolling interest 12,993 14,107
Total Equity 17,146 24,044
Total Liabilities and Stockholders' Equity $ 44,188 $ 51,600